CDKN2B Antikörper

Produktnummer ABIN7182212

Produktdetails anti-CDKN2B Antikörper

Target: CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDKN2B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from Human p15 INK antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu CDKN2B

Target: CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))

Andere Bezeichnung: CDKN2B (CDKN2B Produkte)

Synonyme: p14-INK4b antikoerper, cdk4l antikoerper, ink4b antikoerper, mts2 antikoerper, p15 antikoerper, p15ink4b antikoerper, tp15 antikoerper, CDK4I antikoerper, INK4B antikoerper, MTS2 antikoerper, P15 antikoerper, TP15 antikoerper, p15INK4b antikoerper, AV083695 antikoerper, INK4b antikoerper, p15(INK4b) antikoerper, CDKN2A antikoerper, cyclin dependent kinase inhibitor 2B antikoerper, Cyclin-dependent kinase 4 inhibitor B antikoerper, cyclin-dependent kinase inhibitor 2B antikoerper, cyclin-dependent kinase inhibitor 2B L homeolog antikoerper, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) antikoerper, CDKN2B antikoerper, cdn2b antikoerper, cdkn2b antikoerper, cdkn2b.L antikoerper, Cdkn2b antikoerper

Hintergrund:

Background: Interacts strongly with CDK4 and CDK6. Potent inhibitor. Potential effector of TGF-beta induced cell cycle arrest.

Nynke Y. Rots, Blood, Apr 1999, 93: 2721 - 2729.
Stefan Faderl, Clin. Cancer Res., Jul 1999, 5: 1855.
George Wu, Mol. Biol. Cell, Mar 2007, 18: 1018 - 1029.
A. Koenig, Vet. Pathol., Jul 2002, 39: 458.

Aliases: CDK inhibitory protein antibody, CDK4B Inhibitor antibody, Cdkn2b antibody, CDN2B_HUMAN antibody, Cyclin dependent kinase 4 inhibitor B antibody, Cyclin Dependent Kinase Inhibitor 2B antibody, Cyclin dependent kinase inhibitor 2B p15 inhibits CDK4 antibody, Cyclin dependent kinases 4 and 6 binding protein antibody, Cyclin-dependent kinase 4 inhibitor B antibody, INK4B antibody, MTS 2 antibody, MTS-2 antibody, MTS2 antibody, Multiple tumor suppressor 2 antibody, Multiple Tumor Supressor 2 antibody, OTTHUMP00000021154 antibody, OTTHUMP00000021155 antibody, p14 CDK inhibitor antibody, p14 INK4b antibody, p14-INK4b antibody, P15 antibody, p15 CDK inhibitor antibody, p15 inhibits CDK4 antibody, p15 INK4b antibody, p15-INK4b antibody, p15INK4B antibody, TP 15 antibody, TP15 antibody

UniProt: P42772

Pathways: Zellzyklus, Mitotic G1-G1/S Phases